With an aim to strengthen co-innovation between healthcare startups and industry members and accelerate the process of establishing an accessible and technologically advanced healthcare infrastructure, NATHEALTH-Healthcare Federation of India, in collaboration with TiE Mumbai, and with IQVIA as knowledge partner, launched its initiative Reimagining Healthcare: Industry-Startup Interface Series. The initiative will serve as an effective and credible interface that facilitates meaningful partnerships between the healthcare industry and the startup community.
Speaking about the initiative, Dr. Harsh Mahajan, President, NATHEALTH said, “It is the need of the hour to innovate in the healthcare system in India, especially in the post-COVID era. Less capacity of testing, inadequacy in skilled healthcare workforce, infrastructural insufficiency and inefficient management are some of the gaps that exist in the Indian healthcare ecosystem. There is a need to harness technology and innovate through an active and meaningful collaboration between the start-up community and industry. Covid-19 pandemic may have sparked off innovation, but the key is to sustain this entrepreneurial mindset, in the long run, is to address the existing challenges through meaningful collaboration between the startup community and the industry.”
“The onset of coronavirus has fueled the digitization in every sphere. In order to overcome multitude of healthcare challenges, augmenting health infra and digital health are the key focus areas. There is immense opportunity to re-imagine this sector with disruptive technologies such as artificial intelligence, internet of things, healthcare aggregators that are key to improving access to quality care. There is a need to develop citizen centric and consent based digitized health data. Maintaining transparency of information is crucial to ensure better patient outcome,” said Amit Mookim, Managing Director, IQVIA, South Asia and President, TiE Mumbai
Others who spoke at the meeting included Dr Om Manchanda, MD at Dr Lal Path Labs, Meenakshi Nevatia, MD at Stryker India Pvt Ltd, Harshad Reddy, Director-Operations, Apollo Proton Cancer Centre, Dr Vidur Mahajan, AD at Mahajan Imaging Pvt Ltd.